X
Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
(FORTIS)Here is the latest stock price and chart of FORTIS HEALTHCARE. For more details, see the FORTIS HEALTHCARE company fact sheet and quarterly results.
| Live BSE Quotes | Jun 23, 2017 (Close) | ||
|---|---|---|---|
| Price (Rs)172.30 | Open (Rs) 185.00 | High (Rs) 187.60 | Low (Rs) 170.90 |
| % Change-12.96 | Volume 2,869,416 | Value (Rs) 511,685,021 | 52-Week H/L 230.90 / 142.60 |
| Live NSE Quotes | Jun 23, 2017 (Close) | ||
|---|---|---|---|
| Price (Rs)172.50 | Open (Rs) 186.00 | High (Rs) 187.50 | Low (Rs) 168.25 |
| % Change-12.83 | Volume 29,553,250 | Value (Rs) 5,274,850,821 | 52-Week H/L 228.95 / 142.25 |
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 10.59 | P/E Ratio (x) 16.27 | Market Cap (Rs m) 79,736.99 | P/BV (x) 1.99 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
| FORTIS HEALTHCARE Share Price Chart (Rs) - 1 Year | ||
 |
||
|
S&P BSE SENSEX
|
||||||
| PERIOD | ||||||
|
| |
Global financial markets ended the week on a dull note. This was on back of the Federal Reserve's release of its May 2-3 policy meeting minutes.
Cera Sanitaryware declared results for the quarter ended December 2016. Here is our analysis of the result.
Should you subscribe to the IPO of Tejas Networks Ltd?
Don't be surprised to come across some Super Investors there!
Not all small-cap investors see themselves as traders. Some see themselves as business owners.
Equitymaster analyses Offer for Sale (OFS) of BSE Limited, the oldest and one of the largest stock exchanges in the country.
More Views on NewsWhich brings us back to the basic question, why was demonetisation carried out?
Tomorrow comes the IPO of Eris Lifesciences. How will a pharma IPO do in this market?
Commodity options trading is one step closer to reality. Learn how to take advantage of this tremendous opportunity.
In a market full of one-hit-wonders, this investor obviously had a formula that worked. And through the think-and-thin of the market.
Various costs associated with a home loan.
More|
| |
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | Advertise | About | Sitemap
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
